{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:47:09Z","timestamp":1792684029612,"version":"4.5.0"},"reference-count":9,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"DOI":"10.1182\/blood.2026035163","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:32:03Z","timestamp":1792683123000},"page":"2090-2091","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Addressing CAR T-cell exhaustion through gene silencing"],"prefix":"10.1182","volume":"148","author":[{"given":"Robert","family":"Weinkove","sequence":"first","affiliation":[{"name":"1Malaghan Institute of Medical Research"},{"name":"2Health New Zealand Capital, Coast and Hutt Valley"},{"name":"3University of Auckland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-5097","authenticated-orcid":false,"given":"Rachel","family":"Perret","sequence":"additional","affiliation":[{"name":"1Malaghan Institute of Medical Research"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"17","key":"2026102211315775300_bib1","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood.2025032636","article-title":"Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR T-cell therapy) for relapsed or refractory LBCL: the CRC01-01 trial","volume":"148","author":"Kim","year":"2026","journal-title":"Blood"},{"issue":"11","key":"2026102211315775300_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion\u2019","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2026102211315775300_bib3","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1158\/2159-8290.CD-21-1586","article-title":"Sequential single cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin\u2019s lymphoma","volume":"12","author":"Jackson","year":"2022","journal-title":"Cancer Discov"},{"issue":"3","key":"2026102211315775300_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/2326-6066.CIR-18-0351","article-title":"TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma","volume":"7","author":"Josefsson","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2026102211315775300_bib5","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/s41467-022-33793-w","article-title":"Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis","volume":"13","author":"Qin","year":"2022","journal-title":"Nat Commun"},{"issue":"16","key":"2026102211315775300_bib6","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1182\/bloodadvances.2023010016","article-title":"Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions","volume":"7","author":"Major","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"2026102211315775300_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.seminhematol.2024.07.003","article-title":"Tuning CAR T-cell therapies for efficacy and reduced toxicity","volume":"61","author":"Blud","year":"2024","journal-title":"Semin Hematol"},{"issue":"2","key":"2026102211315775300_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ymthe.2021.10.004","article-title":"PD-1 and TIGIT downregulation distinctly affect the effector and early memory phenotypes of CD19-targeting CAR T cells","volume":"30","author":"Lee","year":"2022","journal-title":"Mol Ther"},{"issue":"7749","key":"2026102211315775300_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","article-title":"NR4A transcription factors limit CAR T cell function in solid tumours","volume":"567","author":"Chen","year":"2019","journal-title":"Nature"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/17\/2090\/2595410\/blood_bld-2026-035163-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/17\/2090\/2595410\/blood_bld-2026-035163-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:32:05Z","timestamp":1792683125000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/17\/2090\/571567\/Addressing-CAR-T-cell-exhaustion-through-gene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":9,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026035163","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,22]]},"published":{"date-parts":[[2026,10,22]]}}}